J-code: Drugs administered other than oral method; chemotherapy drugs Drugs administered other than oral method; chemotherapy drugs
1,255 codes
Billing context
J-codes are permanent national codes for drugs and biologicals — most often clinician-administered (buy-and-bill) products paid under Medicare Part B — plus certain immunosuppressive, inhalation (via DME), and oral anticancer/antiemetic drugs. Units are reported in multiples of the dosage in the code descriptor.
| Code | Long descriptor | Payment limit (Q4 2026) | Added | Status |
|---|---|---|---|---|
| J0716 | Injection, centruroides immune f(ab)2, up to 120 milligrams | $5,449.649per UP TO 120MG | Jan 1, 2013 | Active |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | $3.140per 1 MG | Jan 1, 2014 | Active |
| J0720 | Injection, chloramphenicol sodium succinate, up to 1 gm | — | Jan 1, 1982 | Active |
| J0725 | Injection, chorionic gonadotropin, per 1,000 usp units | $14.439per 1000 UNITS | Jan 1, 1986 | Active |
| J0735 | Injection, clonidine hydrochloride, 1 mg | $14.192per 1 MG | Jan 1, 1998 | Active |
| J0736 | Injection, clindamycin phosphate, 300 mg | $1.854per 300 MG | Jul 1, 2023 | Active |
| J0737 | Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg | $2.068per 300 MG | Jul 1, 2023 | Active |
| J0738 | Injection, lenacapavir, 1 mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv) | $16.016per 1 MG | Oct 1, 2025 | Active |
| J0739 | Injection, cabotegravir, 1mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv) | $7.278per 1 mg | Jul 1, 2022 | Active |
| J0740 | Injection, cidofovir, 375 mg | $522.238per 375 MG | Jan 1, 1998 | Active |
| J0741 | Injection, cabotegravir and rilpivirine, 2mg/3mg | $24.649per 2MG/3MG | Oct 1, 2021 | Active |
| J0742 | Injection, imipenem 4 mg, cilastatin 4 mg and relebactam 2 mg | $2.696per 4 MG-4 MG-2 MG | Jul 1, 2020 | Active |
| J0743 | Injection, cilastatin sodium; imipenem, per 250 mg | $6.796per 250 MG | Jan 1, 1993 | Active |
| J0744 | Injection, ciprofloxacin for intravenous infusion, 200 mg | $1.930per 200 MG | Jan 1, 2002 | Active |
| J0745 | Injection, codeine phosphate, per 30 mg | — | Jan 1, 1986 | Active |
| J0750 | Emtricitabine 200mg and tenofovir disoproxil fumarate 300mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv) | $0.451per 200 mg/300 mg | Jan 2, 2024 | Active |
| J0751 | Emtricitabine 200mg and tenofovir alafenamide 25mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv) | $74.941per 200 mg/25 mg | Jan 2, 2024 | Active |
| J0752 | Oral, lenacapavir, 300 mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv) | $617.946per 300 MG | Oct 1, 2025 | Active |
| J0759 | Injection, clevidipine butyrate, 1 mg | $2.950per 1 MG | Oct 1, 2025 | Active |
| J0760 | Injection, colchicine, per 1 mg | — | Jan 1, 1982 | Ended Dec 31, 2016 |
| J0770 | Injection, colistimethate sodium, up to 150 mg | $18.051per 150 MG | Jan 1, 1982 | Active |
| J0775 | Injection, collagenase, clostridium histolyticum, 0.01 mg | $81.072per 0.01 MG | Jan 1, 2011 | Active |
| J0780 | Injection, prochlorperazine, up to 10 mg | $2.475per 10 MG | Jan 1, 1984 | Active |
| J0791 | Injection, crizanlizumab-tmca, 5 mg | $129.949per 5 MG | Jul 1, 2020 | Active |
| J0795 | Injection, corticorelin ovine triflutate, 1 microgram | — | Jan 1, 2006 | Ended Dec 31, 2025 |
| J0799 | Fda approved prescription drug, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv), not otherwise classified | — | Jan 2, 2024 | Active |
| J0800 | Injection, corticotropin, up to 40 units | — | Jan 1, 1982 | Ended Sep 30, 2023 |
| J0801 | Injection, corticotropin (acthar gel), up to 40 units | $3,884.267per 40 UNITS | Oct 1, 2023 | Active |
| J0802 | Injection, corticotropin (ani), up to 40 units | $3,646.455per up to 40 Units | Oct 1, 2023 | Active |
| J0833 | Injection, cosyntropin, not otherwise specified, 0.25 mgNOC / NOS | — | Jan 1, 2010 | Ended Dec 31, 2018 |
| J0834 | Injection, cosyntropin, 0.25 mg | $22.176per 0.25 MG | Jan 1, 2010 | Active |
| J0840 | Injection, crotalidae polyvalent immune fab (ovine), up to 1 gram | $2,044.383per UP TO 1 GM | Jan 1, 2012 | Active |
| J0841 | Injection, crotalidae immune f(ab')2 (equine), 120 mg | $1,084.909per 120 MG | Jan 1, 2019 | Active |
| J0850 | Injection, cytomegalovirus immune globulin intravenous (human), per vial | $1,857.125per PER VIAL | Jan 1, 1982 | Active |
| J0870 | Injection, imetelstat, 1 mg | $59.355per 1 MG | Jan 1, 2025 | Active |
| J0871 | Injection, daptomycin (endo), not therapeutically equivalent to j0878, 1 mg | $0.541per 1 MG | Oct 1, 2026 | Active |
| J0872 | Injection, daptomycin (xellia), unrefrigerated, not therapeutically equivalent to j0878 or j0873, 1 mg | $0.060per 1 MG | Jul 1, 2024 | Active |
| J0873 | Injection, daptomycin (xellia), not therapeutically equivalent to j0878 or j0872, 1 mg | $0.048per 1 MG | Jan 1, 2024 | Active |
| J0874 | Injection, daptomycin (baxter), not therapeutically equivalent to j0878, 1 mg | $0.062per 1 MG | Oct 1, 2023 | Active |
| J0875 | Injection, dalbavancin, 5 mg | $9.439per 5 MG | Jan 1, 2016 | Active |
| J0877 | Injection, daptomycin (hospira), not therapeutically equivalent to j0878, 1 mg | $0.022per 1 MG | Jan 1, 2023 | Active |
| J0878 | Injection, daptomycin, 1 mg | $0.027per 1 MG | Jan 1, 2005 | Active |
| J0879 | Injection, difelikefalin, 0.1 microgram, (for esrd on dialysis) | — | Apr 1, 2022 | Active |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | $3.081per 1 MCG | Jan 1, 2006 | Active |
| J0882 | Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis) | $3.081per 1 MCG | Jan 1, 2006 | Active |
| J0883 | Injection, argatroban, 1 mg (for non-esrd use) | $0.772per 1 MG | Jan 1, 2017 | Active |
| J0884 | Injection, argatroban, 1 mg (for esrd on dialysis) | $0.772per 1 MG | Jan 1, 2017 | Active |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | $6.669per 1000 UNITS | Jan 1, 2006 | Active |
| J0886 | Injection, epoetin alfa, 1000 units (for esrd on dialysis) | — | Jan 1, 2006 | Ended Dec 31, 2015 |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | $1.196per 1 MCG | Jan 1, 2015 | Active |
| J0888 | Injection, epoetin beta, 1 microgram, (for non esrd use) | $1.196per 1 MCG | Jan 1, 2015 | Active |
| J0889 | Daprodustat, oral, 1 mg, (for esrd on dialysis) | — | Oct 1, 2023 | Ended Dec 31, 2025 |
| J0890 | Injection, peginesatide, 0.1 mg (for esrd on dialysis) | — | Jan 1, 2013 | Active |
| J0891 | Injection, argatroban (accord), not therapeutically equivalent to j0883, 1 mg (for non-esrd use) | — | Jan 1, 2023 | Active |
| J0892 | Injection, argatroban (accord), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis) | — | Jan 1, 2023 | Active |
| J0893 | Injection, decitabine (sun pharma), not therapeutically equivalent to j0894, 1 mg | — | Jan 1, 2023 | Active |
| J0894 | Injection, decitabine, 1 mg | $1.098per 1 MG | Jan 1, 2007 | Active |
| J0895 | Injection, deferoxamine mesylate, 500 mg | $8.777per 500 MG | Jan 1, 1992 | Active |
| J0896 | Injection, luspatercept-aamt, 0.25 mg | $43.484per 0.25 MG | Jul 1, 2020 | Active |
| J0897 | Injection, denosumab, 1 mg | $29.856per 1 MG | Jan 1, 2012 | Active |
| J0898 | Injection, argatroban (auromedics), not therapeutically equivalent to j0883, 1 mg (for non-esrd use) | $1.206per 1 MG | Jan 1, 2023 | Active |
| J0899 | Injection, argatroban (auromedics), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis) | $1.206per 1 MG | Jan 1, 2023 | Active |
| J0900 | Injection, testosterone enanthate and estradiol valerate, up to 1 cc | — | Jan 1, 1982 | Ended Dec 31, 2014 |
| J0901 | Vadadustat, oral, 1 mg (for esrd on dialysis) | $0.125per 1 MG | Jan 1, 2025 | Active |
| J0911 | Instillation, taurolidine 1.35 mg and heparin sodium 100 units (central venous catheter lock for adult patients receiving chronic hemodialysis) | — | Jul 1, 2024 | Active |
| J0945 | Injection, brompheniramine maleate, per 10 mg | — | Jan 1, 1982 | Active |
| J1000 | Injection, depo-estradiol cypionate, up to 5 mg | $53.805per 5 MG | Jan 1, 1982 | Active |
| J1010 | Injection, methylprednisolone acetate, 1 mg | $0.123per 1 MG | Apr 1, 2024 | Active |
| J1020 | Injection, methylprednisolone acetate, 20 mg | — | Jan 1, 1982 | Ended Mar 31, 2024 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | — | Jan 1, 1982 | Ended Mar 31, 2024 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | — | Jan 1, 1982 | Ended Mar 31, 2024 |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | — | Jan 1, 2013 | Active |
| J1060 | Injection, testosterone cypionate and estradiol cypionate, up to 1 ml | — | Jan 1, 1982 | Ended Dec 31, 2014 |
| J1070 | Injection, testosterone cypionate, up to 100 mg | — | Jan 1, 1982 | Ended Dec 31, 2014 |
| J1071 | Injection, testosterone cypionate, 1 mg | $0.023per 1 MG | Jan 1, 2015 | Active |
| J1072 | Injection, testosterone cypionate (azmiro), 1 mg | $1.301per 1 MG | Apr 1, 2025 | Active |
| J1073 | Testosterone pellet, implant, 75 mg | — | Jan 1, 2026 | Active |
| J1080 | Injection, testosterone cypionate, 1 cc, 200 mg | — | Jan 1, 1982 | Ended Dec 31, 2014 |
| J1094 | Injection, dexamethasone acetate, 1 mg | — | Jan 1, 2003 | Ended Mar 31, 2025 |
| J1095 | Injection, dexamethasone 9 percent, intraocular, 1 microgram | — | Jan 1, 2019 | Active |
| J1096 | Dexamethasone, lacrimal ophthalmic insert, 0.1 mg | $87.902per 0.1 MG | Oct 1, 2019 | Active |
| J1097 | Phenylephrine 10.16 mg/ml and ketorolac 2.88 mg/ml ophthalmic irrigation solution, 1 ml | — | Oct 1, 2019 | Active |
| J1098 | Articaine ophthalmic, 8% solution, 0.4 ml | — | Apr 1, 2026 | Active |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | $0.099per 1 MG | Jan 1, 1982 | Active |
| J1105 | Dexmedetomidine, oral, 1 mcg | — | Jan 1, 2024 | Active |
| J1110 | Injection, dihydroergotamine mesylate, per 1 mg | $56.507per 1 MG | Jan 1, 1982 | Active |
| J1120 | Injection, acetazolamide sodium, up to 500 mg | $23.951per 500 MG | Jan 1, 1982 | Active |
| J1130 | Injection, diclofenac sodium, 0.5 mg | — | Jan 1, 2017 | Active |
| J1160 | Injection, digoxin, up to 0.5 mg | $3.809per 0.5 MG | Jan 1, 1982 | Active |
| J1162 | Injection, digoxin immune fab (ovine), per vial | $5,711.373per PER VIAL | Jan 1, 2006 | Active |
| J1163 | Injection, diltiazem hydrochloride, 0.5 mg | $0.027per 0.5 MG | Jul 1, 2025 | Active |
| J1164 | Injection, diltiazem hydrochloride in 0.72% sodium chloride, 0.5 mg | $0.176per 0.5 MG | Apr 1, 2026 | Active |
| J1165 | Injection, phenytoin sodium, per 50 mg | $0.513per 50 MG | Jan 1, 1982 | Active |
| J1170 | Injection, hydromorphone, up to 4 mg | — | Jan 1, 1982 | Ended Sep 30, 2024 |
| J1171 | Injection, hydromorphone, 0.1 mg | $0.224per 0.1 MG | Oct 1, 2024 | Active |
| J1180 | Injection, dyphylline, up to 500 mg | — | Jan 1, 1982 | Active |
| J1190 | Injection, dexrazoxane hydrochloride, per 250 mg | $30.832per 250 MG | Jan 1, 1997 | Active |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | $0.855per 50 MG | Jan 1, 1982 | Active |
| J1201 | Injection, cetirizine hydrochloride, 0.5 mg | $17.073per 0.5 MG | Jul 1, 2020 | Active |
| J1202 | Miglustat, oral, 65 mg | — | Apr 1, 2024 | Active |